Andrew Huberman
@hubermanlab·7.5M subscribers·510 videos
Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast
Posted
August 7, 2023
Views
608,298
Likes
12,673
Comments
1,597
Engagement
August 7, 2023
608,298
12,673
1,597
2.35%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:42:41Now PlayingIn this episode, I explain how ketamine causes rewiring of brain circuits and dissociative states to relieve symptoms of depression and post-traumatic stress disorder (PTSD). I explain how ketamine impacts both the brain’s glutamate and its endogenous opioid pathways, which together regulate mood and well-being. I discuss how ketamine therapy is used clinically to treat major depression, bipolar depression, obsessive-compulsive disorder (OCD), suicidality and other psychiatric challenges. I also describe how ketamine causes the subjective effects of dissociation and euphoria and, at higher doses, is an anesthetic. I compare the different routes of ketamine administration, dosages and forms of ketamine, and if micro-dosing ketamine is effective. I also highlight the potential risks of recreational ketamine use (and the colloquial term ‘K-holes’). This episode should interest anyone interested in ketamine, treatments for depression, neuroplasticity mechanisms, psychiatry and mental health.
#HubermanLab #Science
Thank you to our sponsors
Eight Sleep
Supplements from Momentous
Social & Website
Articles
Antidepressant effects of ketamine in depressed patients
Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism
atai Life Sciences Announces Results from Phase 2a Trial of PCN101 (Rketamine) for TreatmentResistant Depression
Comparative effects of (S)ketamine and racemic (R/S)ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers
Ketamine Metabolite (2R,6R)Hydroxynorketamine Interacts with μ and κ Opioid Receptors
Other Resources
The Science & Treatment of Bipolar Disorder (Huberman Lab episode)
Timestamps
The Huberman Lab podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user’s own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions.
Title Card Photo CreditMike Blabac
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
